Anebulo Pharmaceuticals Inc Sales to Operating Cash Flow Ratio is -0.00 for the year ending December 31, 2023, a 0.00% change year over year. Sales to operating cash flow ratio measures the revenue generated by a company relative to its operating cash flow. It is calculated by dividing the revenue by the operating cash flow. This ratio provides insights into the efficiency of revenue generation compared to the company's operating cash flow. A higher sales to operating cash flow ratio suggests better revenue generation efficiency.